These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 22410060)

  • 1. Living donor liver transplantation for hepatocellular carcinoma: current status in Korea.
    Lee SG; Moon DB; Shin H; Kim KH; Ahn CS; Ha TY; Song GW; Jung DH; Park GC
    Transplant Proc; 2012 Mar; 44(2):520-2. PubMed ID: 22410060
    [No Abstract]   [Full Text] [Related]  

  • 2. Should the liver transplant criteria for hepatocellular carcinoma be different for deceased donation and living donation?
    Grant D; Fisher RA; Abecassis M; McCaughan G; Wright L; Fan ST
    Liver Transpl; 2011 Oct; 17 Suppl 2():S133-8. PubMed ID: 21634006
    [No Abstract]   [Full Text] [Related]  

  • 3. Should we use living donor grafts for patients with hepatocellular carcinoma? Ethical considerations.
    Pomfret EA; Lodge JP; Villamil FG; Siegler M
    Liver Transpl; 2011 Oct; 17 Suppl 2():S128-32. PubMed ID: 21656657
    [No Abstract]   [Full Text] [Related]  

  • 4. Should we perform deceased donor liver transplantation after living donor liver transplantation has failed?
    Greig PD; Geier A; D'Alessandro AM; Campbell M; Wright L
    Liver Transpl; 2011 Oct; 17 Suppl 2():S139-46. PubMed ID: 21563294
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatocellular carcinoma and liver transplantation.
    Washburn K; Halff G
    Curr Opin Organ Transplant; 2011 Jun; 16(3):297-300. PubMed ID: 21505342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended criteria for living donor liver transplantation in patients with advanced hepatocellular carcinoma.
    Choi HJ; Kim DG; Na GH; Hong TH; You YK
    Transplant Proc; 2012 Mar; 44(2):399-402. PubMed ID: 22410027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
    Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
    Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection criteria for patients with hepatocellular carcinoma in liver transplantation.
    Kaido T; Takada Y; Uemoto S
    Transplantation; 2009 Aug; 88(3):442-3; author reply 443. PubMed ID: 19667951
    [No Abstract]   [Full Text] [Related]  

  • 9. Living donor liver transplantation in patients who have received pretransplant treatment for hepatocellular carcinoma.
    Yoshizumi T; Shirabe K; Soejima Y; Taketomi A; Ikegami T; Uchiyama H; Harada N; Ijichi H; Maehara Y
    Transplantation; 2011 Apr; 91(8):e61-2. PubMed ID: 21475066
    [No Abstract]   [Full Text] [Related]  

  • 10. [Selection criteria decisive in hepatocellular carcinoma].
    Söderdahl G; Eilard MS; Rizell M
    Lakartidningen; 2012 Sep 26-Oct 9; 109(39-40):1750-3. PubMed ID: 23097883
    [No Abstract]   [Full Text] [Related]  

  • 11. Should we expand the criteria for liver transplantation for hepatocellular carcinoma--yes, of course!
    Broelsch CE; Frilling A; Malago M
    J Hepatol; 2005 Oct; 43(4):569-73. PubMed ID: 16120470
    [No Abstract]   [Full Text] [Related]  

  • 12. Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival.
    Vakili K; Pomposelli JJ; Cheah YL; Akoad M; Lewis WD; Khettry U; Gordon F; Khwaja K; Jenkins R; Pomfret EA
    Liver Transpl; 2009 Dec; 15(12):1861-6. PubMed ID: 19938113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of HCC patients for liver transplantation: the Milan criteria, Hangzhou criteria and beyond.
    Fan ST
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):233-4. PubMed ID: 18522876
    [No Abstract]   [Full Text] [Related]  

  • 14. Section 4. Further expanding the criteria for HCC in living donor liver transplantation: the Tokyo University experience.
    Tamura S; Sugawara Y; Kokudo N
    Transplantation; 2014 Apr; 97 Suppl 8():S17-20. PubMed ID: 24849823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: the controversies continue.
    Lee HS
    Dig Dis; 2007; 25(4):296-8. PubMed ID: 17960062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
    Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
    Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent hepatocellular carcinoma after living donor liver transplantation: a preventable problem or an acceptable risk?
    Sonnenday CJ
    Ann Surg Oncol; 2010 Sep; 17(9):2262-3. PubMed ID: 20431956
    [No Abstract]   [Full Text] [Related]  

  • 18. Should we expand the criteria for hepatocellular carcinoma with living-donor liver transplantation?--no, never.
    Hiatt JR; Carmody IC; Busuttil RW
    J Hepatol; 2005 Oct; 43(4):573-7. PubMed ID: 16112768
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic importance of the gross classification of hepatocellular carcinoma in living donor-related liver transplantation.
    Shirabe K; Aishima S; Taketomi A; Soejima Y; Uchiyama H; Kayashima H; Ninomiya M; Mano Y; Maehara Y
    Br J Surg; 2011 Feb; 98(2):261-7. PubMed ID: 21072849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center.
    Lee SG; Hwang S; Moon DB; Ahn CS; Kim KH; Sung KB; Ko GY; Park KM; Ha TY; Song GW
    Liver Transpl; 2008 Jul; 14(7):935-45. PubMed ID: 18581465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.